WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: RESIDUAL CANCER BURDEN

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on RESIDUAL CANCER BURDEN

Proof of use for RESIDUAL CANCER BURDEN

We do not have any records of a proof of use for RESIDUAL CANCER BURDEN at this moment.

Click here to add a proof of use for RESIDUAL CANCER BURDEN

Possible trademark infringements of RESIDUAL CANCER BURDEN

Basic Information about RESIDUAL CANCER BURDEN

Serial Number
97205532
Filing Date
06 Jan 2022
Mark Drawing Code
4

Classifications

Declare the trademark use of RESIDUAL CANCER BURDEN on the blockchain with WikiTrademarks.io.

First use of RESIDUAL CANCER BURDEN anywhere
RESIDUAL CANCER BURDEN was first used on 01 Oct 2007 for the primary classification of goods and services, international, 010 (Medical Apparatus)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
010
US Codes
026; 039; 044
First use of RESIDUAL CANCER BURDEN anywhere
RESIDUAL CANCER BURDEN was first used on 01 Oct 2007 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
042
US Codes
100; 101
First use of RESIDUAL CANCER BURDEN anywhere
RESIDUAL CANCER BURDEN was first used on 01 Oct 2007 for the primary classification of goods and services, international, 044 (Medical, beauty & agricultural)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
044
US Codes
100; 101
First use of RESIDUAL CANCER BURDEN anywhere
RESIDUAL CANCER BURDEN was first used on 01 Oct 2007 for the primary classification of goods and services, international, 045 (Personal)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
045
US Codes
100; 101

Who owns RESIDUAL CANCER BURDEN?

1. Delphi Diagnostics, Inc. Houston TX

Correspondent

Naira Simmons
FisherBroyles, LLP
32 School Ln
Scarsdale NY 10583

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on RESIDUAL CANCER BURDEN